HomepageBIOG-B • STO
add
BioGaia AB
Vorige slotkoers
kr 108,40
Dag-range
kr 107,20 - kr 108,80
Jaar-range
kr 93,45 - kr 136,60
Beurswaarde
10,56Â mld. SEK
Gem. volume
318,34K
Koers/winst
-
Dividendrendement
-
Primaire beurs
STO
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (SEK) | jun 2024info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 384,12Â mln. | 21,86% |
Bedrijfskosten | 142,86Â mln. | 2,14% |
Netto inkomsten | 111,01Â mln. | 37,82% |
Netto winstmarge | 28,90 | 13,11% |
Winst per aandeel | — | — |
EBITDA | 147,33Â mln. | 58,38% |
Effectief belastingtarief | 22,24% | — |
Balans
Totale activa
Totale passiva
| (SEK) | jun 2024info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 1,01Â mld. | -26,42% |
Totale activa | 1,90Â mld. | -11,88% |
Totale passiva | 325,40Â mln. | 19,08% |
Totaal aandelenvermogen | 1,58 mld. | — |
Uitstaande aandelen | 100,98 mln. | — |
Koers-boekwaardeverhouding | 6,95 | — |
Rendement op activa | 16,11% | — |
Rendement op kapitaal | 18,86% | — |
Kasstroom
Nettomutatie in liquide middelen
| (SEK) | jun 2024info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 111,01Â mln. | 37,82% |
Operationele kasstroom | 119,12Â mln. | 13,94% |
Kasstroom uit beleggingen | -2,24Â mln. | 90,87% |
Kasstroom uit financiering | -699,12Â mln. | -136,40% |
Nettomutatie in liquide middelen | -583,65Â mln. | -176,28% |
Vrije kasstroom | 100,27Â mln. | 67,38% |
Over
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
Opgericht
1990
Website
Werknemers
220
